The weekly litigation news digest is live. Subscribe now

IP Verse

Compositions And Methods For Targeted Depletion, Enrichment, And Partitioning Of Nucleic Acids Using Crispr/Cas System Proteins - EP3234200

The patent EP3234200 was granted to ARC BIO on Jul 7, 2021. The application was filed on Dec 19, 2015 under application number EP15871259A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3234200

ARC BIO
Application Number
EP15871259A
Filing Date
Dec 19, 2015
Status
Granted And Under Opposition
Jun 12, 2021
Publication Date
Jul 7, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
JUMPCODE GENOMICSApr 7, 2022J A KEMPWITHDRAWN

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2005053947
INTERNATIONAL-SEARCH-REPORTUS2014356867
INTERNATIONAL-SEARCH-REPORTWO2013142578
OPPOSITIONEP3150718
OPPOSITIONUS2014134610
OPPOSITIONUS2014356867
OPPOSITIONWO2014182574
OPPOSITIONWO2015119941
OPPOSITIONWO2015122967
OPPOSITIONWO2015123314
OPPOSITIONWO2015183025
OPPOSITIONWO2016100955
SEARCHUS2014134610
SEARCHUS2014356867
SEARCHWO2015119941
SEARCHWO2015122967

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents